Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function.
about
Pathogenesis of human immunodeficiency virus infectionUse of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells.Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens.Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells.Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.Comparison of splenectomy effects as an indication for host response to growth of primary and metastatic tumour cells in two murine tumour systems.Cancer cell progression and chemoimmunotherapy--dual effects in the induction of resistance to therapyEfficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanismRecognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes.Structure and function of three novel MHC class I antigens derived from a C3H ultraviolet-induced fibrosarcoma.E3/19K from adenovirus 2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class I proteins.Selective acceptance of MHC class I-deficient tumor grafts in the brainAcute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognizedA tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target.Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunityAutocrine induction of major histocompatibility complex class I antigen expression results from induction of beta interferon in oncogene-transformed BALB/c-3T3 cellsRejection of B16 melanoma induced by expression of a transfected major histocompatibility complex class I gene.Viral gene inhibition of class I major histocompatibility antigen expression: not a general mechanism governing the tumorigenicity of adenovirus type 2-, adenovirus type 12-, and simian virus 40-transformed Syrian hamster cellsClass I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.Molecular characterization of novel H-2 class I molecules expressed by a C3H UV-induced fibrosarcoma.The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.Expression of beta 2-microglobulin by human benign and malignant mesenchymal and neurogenic tumours.Tumour cell products inhibit both functional and immunoreactive interleukin 2 production by human blood lymphocytes.Properties of mouse melanoma antigen and its secretion mechanism from the cell surface.A correlation between the expression of CD 8 antigen and specific cytotoxicity of tumor-infiltrating lymphocytes.CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene
P2860
Q24634681-C00BDB7E-4550-45FE-89FA-627641593EB2Q30449840-74EC27FF-068F-4F13-948C-D29EF9209C87Q34624721-778D37B9-4CC5-4423-8DAC-2C83C00B64B4Q35977896-7810967E-B07D-4AB7-9E01-80978F7688FAQ35983100-FD5544C0-8AC0-42B4-A45B-0B8AEDE74127Q36019048-24A3E5A0-CA9E-497E-BDC7-1F604060C83AQ36135064-152FCEE4-35A0-450B-80E3-373BDF9D3143Q36327656-82292AE6-3D73-4DE4-A26B-ECC092970F9AQ36351357-76196EEF-7E5A-4709-86FA-5EA337D4DF92Q36351893-223F56ED-6154-4A5F-996E-31C423D4113DQ36352823-AE7A971D-DE63-46CD-A3B1-8F6AACD71C33Q36354202-4BFEBBC1-5523-46CC-BE80-0F404B50F5A4Q36354506-91CA3A3B-14C3-447D-9A89-D39FAB38518CQ36357551-B74CA01C-C395-415D-946F-94F7ED178727Q36362243-1759B43C-6D61-4106-AAF4-C5C28FC8B5DDQ36366051-5F199095-DCE2-4F3E-B1FF-C48B0C76EE3DQ36776973-10488E2E-4E1B-40EA-B308-1606D9409E82Q36787787-1B3B7477-BBF1-4FD2-B0E3-81AB233409BFQ36878484-168601B7-E51E-4892-973A-7D58F99B4067Q37545192-55983153-0B62-4B7E-A07A-6DA8A4F516BFQ37546796-4F5D50AC-2A5A-4FA8-936B-DD09111B4122Q38513534-B2712EF9-72CF-42E1-B763-568CA1A43B4CQ41151764-7B3C6B8E-5C0D-4C1F-AD37-72C40A8198C9Q43050911-D1495D41-307C-4CA6-AC72-1CE8CD92DB17Q54966173-12C37FA3-F777-41DA-9CDA-861FCB1A0782Q55337277-7117D2C3-D079-494E-B750-92251F54F4ACQ56798245-0A616742-2A15-40C5-B279-1232F6A5BAAA
P2860
Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Immunological surveillance of ...... estriction of T cell function.
@en
type
label
Immunological surveillance of ...... estriction of T cell function.
@en
prefLabel
Immunological surveillance of ...... estriction of T cell function.
@en
P2093
P1476
Immunological surveillance of ...... estriction of T cell function.
@en
P2093
Doherty PC
Knowles BB
Wettstein PJ
P577
1984-01-01T00:00:00Z